DEF 14A: Complete Solaria Sets Date for 2024 Annual Stockholders Meeting, Seeks Approval for Key Proposals

Complete Solaria has scheduled its 2024 annual meeting of stockholders for December 18, 2024, to vote on the election of directors, ratification of the accounting firm, and approval of share issuances related to convertible notes and a purchase agreement.

Summary

• Complete Solaria will hold its 2024 annual meeting of stockholders virtually on December 18, 2024, at 11:00 a.m. Pacific Time.
• Stockholders of record as of October 25, 2024, are eligible to vote.
• The meeting will address the election of nine director nominees, ratification of BDO USA, P.C. as the independent accounting firm, and approval for the issuance of common stock related to the 7.0% Convertible Notes due 2029 and the White Lion Purchase Agreement.
• The company is seeking stockholder approval to issue shares of common stock upon conversion of the 7.0% Convertible Notes due 2029 in an amount that may be equal to or exceed 20% of its outstanding common stock, as required by Nasdaq Listing Rule 5635(d).
• A similar approval is sought for the issuance of shares under the White Lion Purchase Agreement, also to comply with Nasdaq Listing Rule 5635(d).
• The proxy materials were mailed around November 13, 2024.
• Georgeson LLC has been hired to assist in the proxy solicitation process for a fee of approximately $25,000, plus customary costs and expenses.

Sentiment

Score: 6

Explanation: The document is neutral in tone, providing factual information about the upcoming annual meeting and proposals. The potential dilution is a concern, but the company is taking necessary steps to secure financing.

Positives

• The company is taking steps to comply with Nasdaq listing rules regarding share issuances.
• The company has engaged a proxy solicitor to ensure stockholder participation.
• The company is providing multiple avenues for stockholders to vote, including online, telephone, and mail.

Negatives

• Approval of Proposal No. 3 and Proposal No. 4 could lead to significant dilution for existing stockholders.
• If Proposal No. 3 is not approved, the company may be required to repay its obligations under the 7.0% Convertible Notes due 2029 in cash, which may strain its capital resources.
• If Proposal No. 4 is not approved, the company will be limited in its ability to issue shares of Common Stock pursuant to the White Lion Purchase Agreement.

Risks

• Failure to obtain stockholder approval for share issuances could limit the company's financial flexibility.
• The company may face an event of default under the 7.0% Convertible Notes due 2029 if it cannot issue shares and lacks sufficient cash for conversion obligations.
• The market price of the company's common stock could decline due to the potential issuance of new shares.
• The company previously identified material weaknesses in its internal control over financial reporting.

Future Outlook

The company's ability to successfully implement its business plans and ultimately generate value for its stockholders is dependent upon its ability to raise capital and satisfy its ongoing business needs.

Management Comments

• On behalf of our Board of Directors, thank you for your participation in this important process.
• The Board of Directors believes this approach best suits our needs at this stage for the Company.
• While the Board of Directors has not identified appropriate candidates, the Board of Directors intends to cause the Company to comply with the Nasdaq diversity rules (and other applicable diversity requirements) by adding qualified persons to the Board of Directors at a later date in accordance with the Nasdaq diversity rules (and other applicable diversity requirements).

Industry Context

The proposals related to share issuances are common in the current market environment, where companies are seeking flexible financing options. The outcome of the votes will significantly impact Complete Solaria's capital structure and its ability to execute its strategic plans.

Comparison to Industry Standards

• The use of convertible notes and equity lines of credit are common financing tools in the solar industry, particularly for companies seeking growth capital.
• Comparable companies like SunPower (from whom Complete Solaria acquired assets) and Enphase Energy (where T.J. Rodgers serves on the board) also utilize various financing strategies to support their operations and expansion.
• The potential dilution from the proposed share issuances should be assessed in the context of industry norms and the company's growth prospects.

Related Party Transactions

• On January 31, 2024, we entered into a simple agreement for future equity (the First SAFE) with the Rodgers Massey Freedom and Free Markets Charitable Trust (the Purchaser) in connection with the Purchaser investing $1.5 million in us.
• On February 15, 2024, we entered into a second simple agreement for future equity (the Second SAFE) with the Purchaser in connection with the Purchaser investing $3.5 million in us.
• On April 21, 2024, we entered into an amendment to each of our First SAFE and Second SAFE with the Rodgers Massey Freedom and Free Markets Charitable Trust to convert the invested amounts into shares of our Common Stock.
• On May 13, 2024, we entered into a further simple agreement for future equity (the Rodgers Group SAFE) with the Purchaser in connection with the Purchasers investment of $1,000,000.
• On October 5, 2023, Complete Solaria entered into an assignment and acceptance agreement (the Assignment Agreement) with Rodgers Massey Revocable Living Trust and other parties.
• On December 18, 2023, the Company entered into separate common stock purchase agreements (the Purchase Agreements) with the Rodgers Massey Freedom and Free Markets Charitable Trust and the Rodgers Massey Revocable Living Trust (each a Purchaser, and together, the Purchasers).
• On July 1, 2024, we entered into an Exchange Agreement (the Exchange Agreement) with CRSEF Solis Holdings, L.L.C., a Delaware limited liability company (Carlyle), Kline Hill Partners Fund LP, a Delaware limited partnership (Kline Fund), Kline Hill Partners IV SPV LLC, a Delaware limited liability company (Kline Partners) and Kline Hill Partners Opportunity IV SPV LLC, a Delaware limited liability company (Kline Opportunity and together with Kline Fund and Kline Partners, Kline Hill).
• On July 1, 2024, we entered into the Purchase Agreements with Kline Hill.
• In addition, in consideration for the entry of Carlyle and Kline Hill into the Exchange Agreement, on July 1, 2024, we entered into that certain Designated Board Observer Agreement with Carlyle Entity and Kline Partners, pursuant to which Kline Partners and Carlyle each have the right to designate a person to attend certain meetings of the Board in solely a non-voting, observer capacity.
• On September 8, 2024, September 11, 2024 and September 22, 2024, we entered into note purchase agreements with certain accredited investors and qualified institutional buyers relating to the sale and issuance of $80.0 million in aggregate principal amount of our 7.0% Convertible Notes due 2029.

Stakeholder Impact

• Approval of the proposals could lead to dilution for existing shareholders.
• Failure to approve the proposals could limit the company's financial flexibility and impact its ability to execute its business plans.
• The outcome of the votes will affect the company's relationship with its lenders and investors.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold the annual meeting on December 18, 2024, and announce the voting results.
• The company will file a Current Report on Form 8-K with the SEC to disclose the final voting results.

Key Dates

Keywords

annual meeting, proxy statement, stockholders, director election, BDO USA, convertible notes, share issuance, White Lion Purchase Agreement, Nasdaq Listing Rule 5635(d), dilution